Used in biomedical research to quantify levels of Glycogen Synthase Kinase (GSK) in human samples, this ELISA kit enables accurate measurement of GSK activity or expression in cell lysates, tissue extracts, or biological fluids. It is widely applied in studies related to insulin signaling, glucose metabolism, and diseases such as type 2 diabetes, Alzheimer’s disease, and certain cancers where GSK dysregulation plays a key role. The assay supports high-throughput screening in drug development and helps evaluate the impact of therapeutic agents on GSK pathways. Its high sensitivity and specificity make it suitable for both basic research and clinical investigation settings.